Literature DB >> 3722720

[Plasma exchange and acyclovir in Behçet's disease].

M Bonnet, D Ouzan, C Trepo.   

Abstract

It has been postulated that Behçet's disease may be a viral induced vasculitis. In the present study plasma exchanges were applied in an attempt to remove circulating immune complexes and restore cellular immunity. High doses of acyclovir were administered in association with plasma exchanges since it has been shown that herpes simplex virus type 1 might be involved in Behçet's vasculitis. Seven patients with severe ocular manifestations of Behçet's disease were selected for the study. Plasma exchanges were carried out at the rate of 3 per week during 3 weeks and then once every two weeks during 3 months followed by 1 per month during 3 months. 45 mg/day/kg acyclovir were administered intravenously for 21 days. At the end of the follow-up period comparative analysis of panretinal fluorescein angiographies before and after treatment showed no change of the fundus lesions in 3 patients, improvement in only 2 patients and significant worsening in 2 patients. The rather negative results of the present trial lead to assume that HSV-1 is not the virus involved, if any, in Behçet's disease. On the other hand, in the present study, the efficiency of plasma exchanges was transient.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3722720

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  2 in total

1.  Plasma exchange in the therapy of Behçet's disease.

Authors:  M B Raizman; C S Foster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

2.  Lessons of the month 2: A case of Behçet's disease: 70% have ophthalmic involvement.

Authors:  Ishna Auluck; Ayesha Karimi; Simon Taylor
Journal:  Clin Med (Lond)       Date:  2019-11       Impact factor: 2.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.